In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein

Since its inception, SARS-CoV-2 has crossed all borders and continues rampaging around the globe, causing profound economic damage and heavy burden on the scientific community and the healthcare fraternity and facilities. With the emergence of new variants, the global pandemic has prolonged and rais...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahanshah, Mohd Fardeen Husain, Anvitha, D., Gupta, Vandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212792/
https://www.ncbi.nlm.nih.gov/pubmed/35757560
http://dx.doi.org/10.1016/j.pce.2022.103188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212792/
https://www.ncbi.nlm.nih.gov/pubmed/35757560
http://dx.doi.org/10.1016/j.pce.2022.103188

Ejemplares similares